Journal: Mediators of Inflammation

Article Title: Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients

doi: 10.1155/2021/5576596

Figure Lengend Snippet: Serum sST2 concentrations were increased in AR patients than in healthy controls. (a) sST2 levels were elevated in the AR group in comparison with the HC group; (b) the serum sST2 levels were higher in the MSAR group than in the MAR and the HC group. sST2: soluble suppressor of tumorigenicity 2; AR: allergic rhinitis; HC: healthy control; MAR: mild allergic rhinitis; MSAR: moderate-severe allergic rhinitis.

Article Snippet: Serum sST2 measurement was performed by an Enzyme-Linked Immunosorbent Assay- (ELISA-) utilizing human sST2 ELISA kit (Proteintech, Rosemont, USA) referring to the manufacturer's instructions.

Techniques: Comparison, Control

Journal: Mediators of Inflammation

Article Title: Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients

doi: 10.1155/2021/5576596

Figure Lengend Snippet: Correlation between serum sST2 levels and TNSS (a), VAS (b), HDM-specific IgE (c), and total IgE (d). sST2: soluble suppressor of tumorigenicity 2; HDM: house dust mite; TNSS: total nasal symptom score; VAS: visual analogue scale.

Article Snippet: Serum sST2 measurement was performed by an Enzyme-Linked Immunosorbent Assay- (ELISA-) utilizing human sST2 ELISA kit (Proteintech, Rosemont, USA) referring to the manufacturer's instructions.

Techniques:

Journal: Mediators of Inflammation

Article Title: Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients

doi: 10.1155/2021/5576596

Figure Lengend Snippet: The serum levels sST2 in the effective group and ineffective group. (a) The sST2 levels were lower in the effective group than in the ineffective group; (b) patients in the effective group exhibited significantly lower sST2 levels post-SLIT than pre-SLIT; (c) no statistical difference was observed in the ineffective group between post-SLIT and pre-SLIT. (d) the change of sST2 levels was higher in the effective group than in the ineffective group. sST2: soluble suppressor of tumorigenicity 2; SLIT: sublingual immunotherapy.

Article Snippet: Serum sST2 measurement was performed by an Enzyme-Linked Immunosorbent Assay- (ELISA-) utilizing human sST2 ELISA kit (Proteintech, Rosemont, USA) referring to the manufacturer's instructions.

Techniques:

Journal: Mediators of Inflammation

Article Title: Serum Soluble ST2 Correlated with Symptom Severity and Clinical Response of Sublingual Immunotherapy for House Dust Mite-Induced Allergic Rhinitis Patients

doi: 10.1155/2021/5576596

Figure Lengend Snippet: ROC curve analysis of serum sST2 in predicting the efficacy of SLIT. ROC: receiver operating characteristic; sST2: soluble suppressor of tumorigenicity 2; SLIT: sublingual immunotherapy.

Article Snippet: Serum sST2 measurement was performed by an Enzyme-Linked Immunosorbent Assay- (ELISA-) utilizing human sST2 ELISA kit (Proteintech, Rosemont, USA) referring to the manufacturer's instructions.

Techniques:

Journal: EJIFCC

Article Title: Soluble ST2 and Galectin-3: What We Know and Don’t Know Analytically

doi:

Figure Lengend Snippet: Information on selected commercially available assays for measurement of sST2 and galectin-3 in human serum/plasma

Article Snippet: MBL International ( www.mblintl.com) , Human ST2 ELISA kit , 0.032 ng/mL , up to 20 ng/mL , <6%.

Techniques: Inter Assay, Enzyme-linked Immunosorbent Assay

Journal: EJIFCC

Article Title: Soluble ST2 and Galectin-3: What We Know and Don’t Know Analytically

doi:

Figure Lengend Snippet: Data on an analytical assay comparison of the Presage ST2 assay, the MBL ST2 assay, and a R&D ST2 assay *

Article Snippet: MBL International ( www.mblintl.com) , Human ST2 ELISA kit , 0.032 ng/mL , up to 20 ng/mL , <6%.

Techniques: Comparison, Clinical Proteomics

Journal: EJIFCC

Article Title: Soluble ST2 and Galectin-3: What We Know and Don’t Know Analytically

doi:

Figure Lengend Snippet: Panel A represents the H000 SR compared to the ELISA at site A; Panel B represents the i2000 SR compared to the ELISA at site A; Panel C represents the i2000 SR compared to the ELISA at site B; Panel D represents the combined i2000 SR data from site A and B compared to the ELISA. A total of 190 samples at site A and 129 samples at site B were analyzed. The grey line represents x=y and the solid black line indicates the Passing-Bablok regression line. Equitations of the regression line and correlation coefficients are shown. Adopted from .

Article Snippet: MBL International ( www.mblintl.com) , Human ST2 ELISA kit , 0.032 ng/mL , up to 20 ng/mL , <6%.

Techniques: Enzyme-linked Immunosorbent Assay

Journal: ESC Heart Failure

Article Title: Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study

doi: 10.1002/ehf2.13660

Figure Lengend Snippet: Demographic and clinical characteristics of the 187 patients at first decompensation

Article Snippet: N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) was measured using Cobas Elecsys kits (Roche Diagnostics), cancer antigen 125 (CA125) by use of an Architect CA 125 II assay (Abbott Diagnostic) and soluble ST2 (sST2) by use of a human soluble neprilysin/CD10 ELISA kit (Aviscera Bioscience).

Techniques:

Journal: ESC Heart Failure

Article Title: Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study

doi: 10.1002/ehf2.13660

Figure Lengend Snippet: Clinical characteristics of patients in 233 episodes studied for possible decompensation

Article Snippet: N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) was measured using Cobas Elecsys kits (Roche Diagnostics), cancer antigen 125 (CA125) by use of an Architect CA 125 II assay (Abbott Diagnostic) and soluble ST2 (sST2) by use of a human soluble neprilysin/CD10 ELISA kit (Aviscera Bioscience).

Techniques: Biomarker Discovery